Concepedia
Statistics
Publications
31
Citations
1.2K
H-Index
20
Active since
2012
Affiliations
Renji Hospital(Current)
Shanghai Jiao Tong University
Ruijin Hospital
The University of Texas MD Anderson Cancer Center
Zhongshan Hospital
Wen Kong is an author at Renji Hospital specializing in medicine, oncology, and renal cell carcinoma.
Publications per year
2012–2024
PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma
Xian-De Liu, Wen Kong, Christine B. Peterson et al. · Nature Communications · 2020 · 176 citations · Full text
Medicine, Immunology, Oncology +17
Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals
Wei Zhai, Saiyang Li, Jin Zhang et al. · Molecular Cancer · 2018 · 77 citations · Full text
Medicine, Oncology, Pharmacology +17
Low Enhancement on Multiphase Contrast-Enhanced CT Images: An Independent Predictor of the Presence of High Tumor Grade of Clear Cell Renal Cell Carcinoma
Zhu Ye-hua, Xun Wang, Jin Zhang et al. · American Journal of Roentgenology · 2014 · 70 citations
Medicine, Oncology, Radiology +17
LSD1 inhibition suppresses the growth of clear cell renal cell carcinoma via upregulating P21 signaling
Liangsong Zhu, Jianfeng Wang, Wen Kong et al. · Acta Pharmaceutica Sinica B · 2018 · 62 citations · Full text
Medicine, Cancer Biology, Oncology +17
Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma
Xiaomao Yin, Zaoyu Wang, Jianfeng Wang et al. · OncoImmunology · 2021 · 55 citations · Full text
Medicine, Bioinformatics, Oncology +17
1–5 of 31